Upfront advanced radiotherapy and new drugs for nsclc patients with synchronous brain metastases: is the juice worth the squeeze? a real-world analysis from lombardy, italy

HIGHLIGHTS

• who: Giulia Corrao and colleagues from the the Squeeze? A Real-World Analysis from Lombardy, Italy National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca have published the article: Upfront Advanced Radiotherapy and New Drugs for NSCLC Patients with Synchronous Brain Metastases: Is the Juice Worth the Squeeze? A Real-World Analysis from Lombardy, Italy, in the Journal: (JOURNAL) of June/30,/2020
• what: The aim of this study is to compare effectiveness and cost profile in non-small-cell lung cancer (NSCLC) patients harboring synchronous brain metastases (BMs) who received nonchemo first . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.